{"metadata": {"source": "erowid", "title": "Erowid Amphetamines Vault : Effects", "description": "Information about the mental and physical effects of Amphetamines.", "language": "No language found.", "url": "https://www.erowid.org/chemicals/amphetamines/amphetamines_effects.shtml", "drug": "Amphetamine", "cid": 3007, "substance": "amphetamines", "category": "CHEMICALS", "erowid_column": "Effects", "char_count": 9991, "word_count": 1371, "doc_id": "doc_105", "num_chunks": 14, "chunk_id": "105::chunk_8", "document_index": 105, "latency_s": 0.7652125000022352, "prompt_toks": 2513, "completion_toks": 63, "relevance_score": 2.0623422e-05}, "content": "Drug: Amphetamine | cid: 3007\nSource: erowid | Source description: Information about the mental and physical effects of Amphetamines.\nErowid name: amphetamines\nCategory: CHEMICALS\nField: Effects\n\n                    Text: \n                    craving\n\nexhaustion\n\ndepression\n\nmental confusion\n\nrestlessness and insomnia\n\ndeep or disturbed sleep lasting up to 48 hours\n\nextreme hunger\n\npsychotic reaction\n\nanxiety reactions\n\nTreatment (from FADAA)\n\n\n                    Context: \n                    This excerpt lists common withdrawal symptoms associated with amphetamine overdose or cessation, including craving, exhaustion, depression, and psychotic reactions, and briefly mentions treatment approaches from the FADAA. It is part of the broader section on amphetamine effects, overdose, and medical management within the webpage's detailed overview of various drugs.\n                "}
{"metadata": {"source": "psychonaut", "title": "Diphenhydramine - PsychonautWiki", "description": "Please use harm reduction practices if using this substance (e.g. starting with a low dose and always having a trip sitter). Refer to this section for more details.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Diphenhydramine", "drug": "Diphenhydramine", "cid": 3100, "char_count": 31970, "word_count": 4517, "doc_id": "doc_74", "num_chunks": 40, "chunk_id": "74::chunk_28", "document_index": 74, "latency_s": 0.9074422999983653, "prompt_toks": 7992, "completion_toks": 76, "relevance_score": 1.7778551e-05}, "content": "Drug: Diphenhydramine | cid: 3100\nSource: psychonaut | Source description: Please use harm reduction practices if using this substance (e.g. starting with a low dose and always having a trip sitter). Refer to this section for more details.\n\n                    Text: \n                    The user may be completely unable to distinguish reality from hallucinations. For this reason there is a significant risk of the user responding to a delusional environment and injuring themselves or others, as well as the possibility of engaging in too much physical activity which can further strain the heart or cause rhabdomyolysis.[20] Individuals experiencing delusions should, if possible, not be agitated. The first lines of treatment for overdose should be benzodiazepines, although medical attention should always be sought.\n\nDiphenhydramine can become fatal at amounts close to or exceeding 2 grams.[citation needed] This can result in death, especially when combined with most stimulants, depressants and MAOIs.\n\nPsychosis\n\n\n                    Context: \n                    This excerpt discusses severe mental and physical risks associated with diphenhydramine overdose, including the potential for psychosis, delusions, and life-threatening conditions such as fatal overdose at doses near 2 grams. It emphasizes the dangers of responding to hallucinations and delusions, highlighting the importance of medical treatment with benzodiazepines and caution when using the substance recreationally.\n                "}
{"metadata": {"source": "psychonaut", "title": "Temazepam - PsychonautWiki", "description": "Temazepam (trade name Restoril) is a short-acting[3] psychoactive substance of the benzodiazepine class which produces anxiolytic, sedative, hypnotic, muscle relaxant, anticonvulsant, and amnesic effects.[4] Temazepam, like other benzodiazepines, binds to specific sites on the GABAA gamma-amino-butyric acid receptor.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Temazepam", "drug": "Temazepam", "cid": 5391, "char_count": 24525, "word_count": 3416, "doc_id": "doc_101", "num_chunks": 30, "chunk_id": "101::chunk_15", "document_index": 101, "latency_s": 0.6731124999932945, "prompt_toks": 6513, "completion_toks": 79, "relevance_score": 5.9551394e-06}, "content": "Drug: Temazepam | cid: 5391\nSource: psychonaut | Source description: Temazepam (trade name Restoril) is a short-acting[3] psychoactive substance of the benzodiazepine class which produces anxiolytic, sedative, hypnotic, muscle relaxant, anticonvulsant, and amnesic effects.[4] Temazepam, like other benzodiazepines, binds to specific sites on the GABAA gamma-amino-butyric acid receptor.\n\n                    Text: \n                    Withdrawal symptoms or rebound symptoms may occur after ceasing usage abruptly following a few weeks or longer of steady dosing, and may necessitate a gradual dose reduction.[20][21] For more information on tapering from benzodiazepines in a controlled manner, please see this guide.\n\nBenzodiazepine discontinuation is notoriously difficult; it is potentially life-threatening for individuals using regularly to discontinue use without tapering their dose over a period of weeks. There is an increased risk of hypertension, seizures, and death.[6] Drugs which lower the seizure threshold such as tramadol should be avoided during withdrawal.\n\nTemazepam presents cross-tolerance with all benzodiazepines, meaning that after its consumption all benzodiazepines will have a reduced effect. Temazepam also has cross-tolerance with all barbiturates, meaning that after consumption, all barbiturates will have a diminished effect.\n\nOverdose\n\n\n                    Context: \n                    This excerpt discusses the risks and challenges of benzodiazepine withdrawal, emphasizing the difficulty and potential dangers of stopping temazepam without tapering, and highlighting its cross-tolerance with other benzodiazepines and barbiturates. It provides essential harm reduction guidance related to dependence, discontinuation, and overdose prevention within the broader context of temazepam's pharmacology and toxicity.\n                "}
